Back

SciSparc says 26 children enrolled in NeuroThera autism drug trial

Verifying
  • NeuroThera advanced enrollment in its SCI-210 autism clinical trial.
  • 26 children have enrolled toward a planned total of 60 participants.
  • Soroka Medical Center is conducting the 20-week, double-blind study in Israel.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.